Open prospective study to evaluate the efficacy of a new vaginal pessary containing 300mg tinidazole, 200mg tioconazole and 100mg lidocaine with a 3-day regime (Gynomax XL®) in the treatment of vaginal infections due to bacterial vaginosis, candidiasis an

Introduction. The management of infections of the vulva and vagina depend on the selection and administration of effective specific therapies that allow a fast treatment, enhancing the compliance of the patients. Objective of the study: the efficacy and safety of a new medicinal product containin...

Full description

Saved in:
Bibliographic Details
Main Authors: P.A. Regidor, M. Sailer
Format: Article
Language:English
Published: Publishing House TRILIST 2024-03-01
Series:Репродуктивная эндокринология
Subjects:
Online Access:https://reproduct-endo.com/article/view/301922
Tags: Add Tag
No Tags, Be the first to tag this record!